# A Study to Assess Disease Activity in Adolescent and Adult Participants With Atopic Dermatitis Who Receive Oral Upadacitinib Tablets in a Real-World Setting

> **NCT05139836** · — · ACTIVE_NOT_RECRUITING · sponsor: **AbbVie** · enrollment: 634 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05139836
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-12-13
- **Primary completion:** 2027-09
- **Final completion:** 2027-09
- **Target enrollment:** 634 (ACTUAL)
- **Last updated:** 2026-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05139836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05139836, "A Study to Assess Disease Activity in Adolescent and Adult Participants With Atopic Dermatitis Who Receive Oral Upadacitinib Tablets in a Real-World Setting". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05139836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*